<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26884" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pemphigus Vulgaris</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ingold</surname>
            <given-names>Curtis J.</given-names>
          </name>
          <aff>University Hospitals</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sathe</surname>
            <given-names>Nishad C.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khan</surname>
            <given-names>Moien AB</given-names>
          </name>
          <aff>United Arab Emirates University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Curtis Ingold declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nishad Sathe declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Moien AB Khan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>3</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26884.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Pemphigus vulgaris is a rare autoimmune disease that causes blistering on cutaneous and mucosal surfaces. As the most prevalent type of pemphigus, its onset typically occurs between ages 40&#x000a0;and&#x000a0;60, affecting both&#x000a0;genders equally. This activity explores the historical context and etiology of PV, tracing back to its initial description in 1788, shedding light on its pathogenesis involving acantholysis, which leads to blister formation.&#x000a0;The course discussion&#x000a0;reviews the role of the interprofessional team in&#x000a0;managing patients with PV,&#x000a0;highlighting collaborative strategies for comprehensive patient care.</p>
        <p>Learners&#x000a0;will gain insights into the evolving understanding of PV, dispelling earlier notions of contagion while exploring potential triggers associated with the onset in individuals with existing autoimmune disorders. This session aims to enhance clinicians' comprehension of the clinical presentation, diagnosis, and management approaches for PV. By fostering collaborative efforts among healthcare professionals, this activity seeks to improve outcomes for individuals affected by&#x000a0;PV&#x000a0;while exploring evolving perspectives on its triggers and management paradigms.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the underlying autoimmune mechanisms and immunological factors involved in the etiology of PV, recognizing the pathophysiological basis of blister formation.</p></list-item><list-item><p>Implement evidence-based evaluation strategies for PV, integrating diagnostic tools and methods to ensure comprehensive assessment.</p></list-item><list-item><p>Determine the optimal&#x000a0;management strategies for&#x000a0;patients with PV,&#x000a0;incorporating&#x000a0;tailored&#x000a0;treatments into patient care plans to improve outcomes.</p></list-item><list-item><p>Coordinate efforts among the interprofessional team to ensure a cohesive and integrated approach to patient care.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26884&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26884">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26884.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Pemphigus vulgaris (PV) is an autoimmune disease that results in blisters on cutaneous and mucosal surfaces and is characterized primarily by acantholysis.<xref ref-type="bibr" rid="article-26884.r1">[1]</xref> Pemphigus is derived from pemphix, the Greek word for blister. Pemphigus was first described in 1788 by Stephen Dickson, who observed a patient with a blister on her tongue.<xref ref-type="bibr" rid="article-26884.r2">[2]</xref>&#x000a0;Although PV is not contagious as initially thought, there have been possible triggers identified that might induce PV in patients with other autoimmune disorders.<xref ref-type="bibr" rid="article-26884.r1">[1]</xref></p>
      </sec>
      <sec id="article-26884.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The precise etiology of pemphigus vulgaris is unknown; however, multiple studies have linked pemphigus vulgaris with autoantibodies targeting cadherins, ultimately leading to acantholysis and dissociation of keratinocytes.<xref ref-type="bibr" rid="article-26884.r3">[3]</xref><xref ref-type="bibr" rid="article-26884.r4">[4]</xref>. Some&#x000a0;patients at risk may have a genetic predisposition for pemphigus vulgaris.<xref ref-type="bibr" rid="article-26884.r5">[5]</xref><xref ref-type="bibr" rid="article-26884.r6">[6]</xref> Several studies have linked PV with human leukocyte antigen (HLA) class II alleles.<xref ref-type="bibr" rid="article-26884.r7">[7]</xref>&#x000a0;HLA-DRB1 0402 is associated with PV in&#x000a0;Ashkenazi Jews; DRB1 1401/04 and DQB1 0503 HLA alleles are associated with PV in non-Jewish patients of European or Asian descent.<xref ref-type="bibr" rid="article-26884.r8">[8]</xref><xref ref-type="bibr" rid="article-26884.r9">[9]</xref><xref ref-type="bibr" rid="article-26884.r10">[10]</xref> Environmental factors, such as diet, stress, viral infections, medications, ultraviolet radiation, ionizing radiation therapy, pesticides, and allergens, may all induce immune dysregulation leading to a flare of PV.<xref ref-type="bibr" rid="article-26884.r1">[1]</xref><xref ref-type="bibr" rid="article-26884.r11">[11]</xref><xref ref-type="bibr" rid="article-26884.r12">[12]</xref></p>
        <p>Exposure to certain&#x000a0;medications like penicillamine and captopril can&#x000a0;trigger PV. Such a trigger can happen through the effects on binding to molecules involved in cell adhesion, influence on enzymes that mediate keratinocyte aggregation, and by stimulating neoantigen formation.<xref ref-type="bibr" rid="article-26884.r13">[13]</xref>&#x000a0;Furthermore,&#x000a0;nonsteroidal antiinflammatory agents, penicillin, and cephalosporins have also been associated with drug-induced PV.<xref ref-type="bibr" rid="article-26884.r13">[13]</xref><xref ref-type="bibr" rid="article-26884.r14">[14]</xref>&#x000a0;Finally, controversial case reports&#x000a0;associating PV with certain foods like red wine, garlic, leek, and peppers exist, though such an association is not supported by robust evidence.<xref ref-type="bibr" rid="article-26884.r15">[15]</xref></p>
      </sec>
      <sec id="article-26884.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Though&#x000a0;PV is prevalent worldwide, the occurrence of PV&#x000a0;may be related to ethnicity and geographic location.<xref ref-type="bibr" rid="article-26884.r16">[16]</xref><xref ref-type="bibr" rid="article-26884.r7">[7]</xref> The reported incidence is between&#x000a0;0.1 and 0.5 per 100,000 people per year.<xref ref-type="bibr" rid="article-26884.r17">[17]</xref>&#x000a0;However, a higher rate is recorded in certain ethnicities.<xref ref-type="bibr" rid="article-26884.r18">[18]</xref>&#x000a0;Ashkenazi Jews have been found to have an increased incidence of PV, and the average onset of PV is usually seen between the ages of 40 and 60 years.<xref ref-type="bibr" rid="article-26884.r19">[19]</xref>&#x000a0;Also, people in&#x000a0;India, Southeast Europe, and the Middle East are at greatest risk for PV.<xref ref-type="bibr" rid="article-26884.r20">[20]</xref>&#x000a0;The prevalence of PV is roughly the same in men and women. However, in Tunisia, PV is more common in women&#x000a0;than&#x000a0;men by a ratio of 4&#x000a0;to 1.<xref ref-type="bibr" rid="article-26884.r1">[1]</xref><xref ref-type="bibr" rid="article-26884.r19">[19]</xref></p>
        <p>PV has been shown to have a genetic component, although familial cases are uncommon.<xref ref-type="bibr" rid="article-26884.r21">[21]</xref> Patients with PV have been found to have a higher frequency of nonsymptomatic first-degree relatives with circulating PV&#x02013;immunoglobulin G (IgG) antibodies compared&#x000a0;with healthy controls. Additionally, first-degree relatives were found to have a higher prevalence of autoimmune diseases. DQB1*0503 and DRB1*0402 are two of the most common PV-associated alleles, with the latter protective against rheumatoid arthritis. PV has been associated with myasthenia gravis and ulcerative colitis.<xref ref-type="bibr" rid="article-26884.r22">[22]</xref><xref ref-type="bibr" rid="article-26884.r23">[23]</xref></p>
      </sec>
      <sec id="article-26884.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>PV&#x000a0;is caused by autoantibodies that target&#x000a0;cadherins, specifically desmogleins, though there may be some role for desmocollin; thus, this is a type 2 hypersensitivity reaction.<xref ref-type="bibr" rid="article-26884.r24">[24]</xref><xref ref-type="bibr" rid="article-26884.r25">[25]</xref> Acantholysis, or&#x000a0;the loss of keratinocyte&#x02013;keratinocyte adhesion, is interrupted by circulating IgG autoantibodies to&#x000a0;intercellular adhesion molecules.<xref ref-type="bibr" rid="article-26884.r26">[26]</xref><xref ref-type="bibr" rid="article-26884.r27">[27]</xref> Acantholysis is seen&#x000a0;as a result of&#x000a0;the autoantibodies destroying the intracellular connections, leading to bullae that can easily rupture&#x000a0;(known clinically as the Nikolsky sign).</p>
        <p>A &#x0201c;super-compensation hypothesis&#x0201d; recently submitted by Sinha et al. proposes that additional factors may also play a role in PV.<xref ref-type="bibr" rid="article-26884.r28">[28]</xref>&#x000a0;Multiple&#x000a0;mechanisms for antibody-induced acantholysis have been suggested, including the induction of signal transduction and the inhibition of adhesive molecule function through steric hindrance, which can trigger&#x000a0;cell separation.<xref ref-type="bibr" rid="article-26884.r29">[29]</xref>&#x000a0;The pathogenesis&#x000a0;of PV has been described in more detail by Hammers et al.<xref ref-type="bibr" rid="article-26884.r30">[30]</xref>&#x000a0;</p>
        <p>In patients with PV, autoantibodies&#x000a0;against desmoglein 1 (Dsg 1) and desmoglein 3 (Dsg 3) is the purported cause.<xref ref-type="bibr" rid="article-26884.r31">[31]</xref> Desmogleins are transmembrane glycoproteins that are an integral part of desmosomes which, in part, are required for cell&#x02013;cell adhesion via interaction with intermediate filaments. The most common targets of desmoglein for IgG antibodies are the extracellular cadherin domains, which can result in the loss of desmosome-adhesive properties.&#x000a0;These signaling pathways trigger endocytosis, depletion, and direct inhibition of Dsg 3 interactions.<xref ref-type="bibr" rid="article-26884.r32">[32]</xref>&#x000a0;It is generally believed that the amino portion of the cadherin proteins is most implicated in the pathogenesis of acantholysis leading to PV.<xref ref-type="bibr" rid="article-26884.r33">[33]</xref></p>
        <p>Many animal models&#x000a0;have shown that enzymatic inactivation of&#x000a0;Dsg 1 and gene deletion of Dsg 3 results in pathology similar to PV.<xref ref-type="bibr" rid="article-26884.r34">[34]</xref><xref ref-type="bibr" rid="article-26884.r35">[35]</xref>&#x000a0;This phenomenon was observed to be dose-dependent and suggests that reducing the circulating levels of IgG against Dsg 1 and Dsg 3 can improve patient outcomes.<xref ref-type="bibr" rid="article-26884.r36">[36]</xref> In patients with primarily cutaneous disease, Dsg 1 likely plays a role more superficially, whereas Dsg 3 is more likely to be found in deeper cutaneous structures and mucous membranes.<xref ref-type="bibr" rid="article-26884.r37">[37]</xref><xref ref-type="bibr" rid="article-26884.r38">[38]</xref>&#x000a0;The implication is that&#x000a0;Dsg 3 can compensate for the absence of&#x000a0;Dsg 1 in mucosal structures (thus demonstrating PV in cutaneous lesions only). In contrast, Dsg 1 without&#x000a0;Dsg 3 is insufficient to manage mucous membranes or cutaneous lesions alone, implying that&#x000a0;Dsg 1 is in lower proportion in mucous membranes.</p>
        <p>The binding of antibodies to desmogleins has been confirmed by epitope mapping and is presumed to disrupt desmoglein binding by affecting steric hindrance.<xref ref-type="bibr" rid="article-26884.r39">[39]</xref> Another&#x000a0;theory for&#x000a0;the pathophysiology of PV is the desmoglein nonassembly depletion hypothesis. This theory suggests that autoantibodies not only bind desmoglein but that they also bind each other, leading to crosslinking and the inability of desmosomes to maintain cell&#x02013;cell adhesion.<xref ref-type="bibr" rid="article-26884.r40">[40]</xref><xref ref-type="bibr" rid="article-26884.r41">[41]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-26884.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Histopathologic evaluation of&#x000a0;PV should be performed with both a hematoxylin and eosin (H&#x00026;E) biopsy on lesional skin that is stored in formalin and a second biopsy for direct immunofluorescence on nonlesional skin that is not stored in formalin but rather in an appropriate medium such as Michel medium.<xref ref-type="bibr" rid="article-26884.r42">[42]</xref><xref ref-type="bibr" rid="article-26884.r43">[43]</xref>&#x000a0;</p>
        <p>The classic histopathologic finding is suprabasilar acantholysis, leaving a tombstone appearance in the remaining basal keratinocytes; there may be eosinophils present as well.<xref ref-type="bibr" rid="article-26884.r44">[44]</xref><xref ref-type="bibr" rid="article-26884.r45">[45]</xref><xref ref-type="bibr" rid="article-26884.r46">[46]</xref>&#x000a0;The pemphigus vegetans variant may have similar findings with additional papillomatosis and hyperkeratosis, often present in&#x000a0;skin folds, such as the inguinal or axillary folds.<xref ref-type="bibr" rid="article-26884.r47">[47]</xref><xref ref-type="bibr" rid="article-26884.r48">[48]</xref></p>
      </sec>
      <sec id="article-26884.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>PV&#x000a0;is a blistering disease that initially presents on the oral mucosa in 80% of cases.<xref ref-type="bibr" rid="article-26884.r3">[3]</xref><xref ref-type="bibr" rid="article-26884.r49">[49]</xref> These intraoral blisters often rupture, leaving painful erosions, which may affect&#x000a0;patients' oral intake, leading to potential malnutrition.<xref ref-type="bibr" rid="article-26884.r50">[50]</xref><xref ref-type="bibr" rid="article-26884.r51">[51]</xref> Cutaneous lesions&#x000a0;traditionally appear in patients with PV after the first oral blisters have presented.<xref ref-type="bibr" rid="article-26884.r52">[52]</xref> Vesicles, erosions, or bullae may appear on erythematous or normal-appearing skin. A Nikolsky sign is described as a blister formation with minor pressure or trauma and is seen in PV.<xref ref-type="bibr" rid="article-26884.r53">[53]</xref>&#x000a0;</p>
        <p>Due to the painful nature of oral lesions, PV can impair nutritional status. Mucosal PV can be found in the conjunctiva, nasal mucosa, larynx, pharynx, esophagus, penis, vagina, and anus.<xref ref-type="bibr" rid="article-26884.r54">[54]</xref>&#x000a0;When presenting in the cervix, PV can elicit a diagnostic challenge by conflating the Pap smear results, which may reveal inauthentic dysplastic changes.<xref ref-type="bibr" rid="article-26884.r54">[54]</xref><xref ref-type="bibr" rid="article-26884.r55">[55]</xref><xref ref-type="bibr" rid="article-26884.r56">[56]</xref>&#x000a0;Cutaneous lesions are commonly found on the face, trunk, groin, scalp, and armpits. PV usually spares the palms and soles.<xref ref-type="bibr" rid="article-26884.r57">[57]</xref> Blisters can heal without scarring but may result in changes in the pigment. Alopecia may be observed when PV affects the scalp.<xref ref-type="bibr" rid="article-26884.r58">[58]</xref> Rarely, PV will involve nails when the disease is severe.<xref ref-type="bibr" rid="article-26884.r19">[19]</xref><xref ref-type="bibr" rid="article-26884.r59">[59]</xref>&#x000a0;Another rare manifestation of PV&#x000a0;is pemphigus herpetiformis, where PV can present with urticarial plaques and cutaneous vesicles arranged in a herpetiform or annular arrangement.</p>
      </sec>
      <sec id="article-26884.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of PV is based on clinical, histopathologic, and laboratory studies.&#x000a0;An H&#x00026;E biopsy should be performed on lesional skin, which can be analyzed to show the characteristic histopathologic findings.&#x000a0;Direct immunofluorescence is&#x000a0;an important tool for the diagnosis of PV, which shows a net-like or chicken wire&#x02013;like pattern of IgG in the epidermis.<xref ref-type="bibr" rid="article-26884.r60">[60]</xref><xref ref-type="bibr" rid="article-26884.r61">[61]</xref> Enzyme-linked immunosorbent assay (ELISA) testing, which is commercially available, will show serum IgG against Dsg 1, Dsg 3, or both in&#x000a0;most&#x000a0;samples.<xref ref-type="bibr" rid="article-26884.r19">[19]</xref><xref ref-type="bibr" rid="article-26884.r59">[59]</xref></p>
        <p>Tzanck smear and histology examination will show acantholysis.<xref ref-type="bibr" rid="article-26884.r19">[19]</xref>&#x000a0;Serological studies like indirect immunofluorescence (IIF), which should be performed on monkey esophagus as a substrate, and ELISA can detect circulating autoantibodies that bind epithelial cell surface antigens.<xref ref-type="bibr" rid="article-26884.r62">[62]</xref><xref ref-type="bibr" rid="article-26884.r63">[63]</xref></p>
        <p>In patients with positive direct immunofluorescence (DIF) results,&#x000a0;ELISA testing will show serum IgG against Dsg 1, Dsg 3, or both.<xref ref-type="bibr" rid="article-26884.r59">[59]</xref>&#x000a0;Additional workup should include vitals, pregnancy testing in select populations, a complete blood count (CBC), a metabolic panel, antinuclear antibody (ANA), and a urinalysis. A bone density scan may be needed early in the disease to ensure proper prevention of osteoporosis in at-risk patients who may be on a longer course of systemic glucocorticoids. Also, quality of life and disease activity should be documented to ensure a baseline for further monitoring. Two validated severity scoring systems include the Pemphigus Disease Area Index (PDAI) and the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS), which can be completed in 2 to 5 minutes.<xref ref-type="bibr" rid="article-26884.r64">[64]</xref></p>
      </sec>
      <sec id="article-26884.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>First-line Treatment</bold>
</p>
        <p>
<bold>Systemic corticosteroids</bold>
</p>
        <p>Systemic corticosteroids have significantly impacted the treatment of&#x000a0;PV and remain the backbone of its management.<xref ref-type="bibr" rid="article-26884.r65">[65]</xref> The first-line treatment of mild PV is systemic corticosteroids, which take several weeks to achieve a response.<xref ref-type="bibr" rid="article-26884.r64">[64]</xref> Tapering down of the dose can be initiated when symptoms are improved, but if the reappearance of more than&#x000a0;3 lesions occurs, dosing should be increased again to induce remission.<xref ref-type="bibr" rid="article-26884.r66">[66]</xref>&#x000a0;</p>
        <p>
<bold>Anti-CD20 monoclonal antibodies</bold>
</p>
        <p>Anti-CD20 monoclonal antibodies, such as rituximab and ofatumumab,&#x000a0;are the preferred modality to use in conjunction with corticosteroids for first-line treatment in moderate-to-severe pemphigus.<xref ref-type="bibr" rid="article-26884.r59">[59]</xref>&#x000a0;Rituximab is an anti-CD20 monoclonal antibody that stops B lymphocytes from maturing into autoantibody-producing plasma cells. It is administered intravenously, and response is usually seen within&#x000a0;3 months. Common side effects include infusion-related reactions such as nausea, vomiting, headache, and fever.<xref ref-type="bibr" rid="article-26884.r66">[66]</xref> A rare serious side effect of rituximab is progressive multifocal leukoencephalopathy (PML), which has also been seen in other monoclonal antibodies.<xref ref-type="bibr" rid="article-26884.r67">[67]</xref></p>
        <p>
<bold>Second-line Treatment</bold>
</p>
        <p>
<bold>Steroid-sparing immunosuppressives</bold>
</p>
        <p>Second-line treatment in combination with corticosteroids may include steroid-sparing immunosuppressives, such as azathioprine or mycophenolate mofetil (MMF).<xref ref-type="bibr" rid="article-26884.r66">[66]</xref>&#x000a0;Azathioprine is a purine analog that inhibits purine synthesis; it can be administered orally or by intravenous infusion. For patients on azathioprine, testing of the&#x000a0;thiopurine methyltransferase (TPMT) enzyme should be performed to ensure that the metabolism of azathioprine is appropriate since the failure of this process may lead to&#x000a0;bone marrow suppression, causing pancytopenia, thrombocytopenia, and leukopenia.<xref ref-type="bibr" rid="article-26884.r68">[68]</xref><xref ref-type="bibr" rid="article-26884.r69">[69]</xref><xref ref-type="bibr" rid="article-26884.r68">[68]</xref>&#x000a0;MMF&#x000a0;functions as an immunosuppressant by inhibiting purine synthesis; it can be administered orally or by intravenous infusion. MMF is usually effective within&#x000a0;2 months of initiating treatment. Common side effects include nausea, vomiting, diarrhea, and abdominal discomfort. Intravenous administration can cause superficial thrombophlebitis and thrombosis.<xref ref-type="bibr" rid="article-26884.r66">[66]</xref></p>
        <p>
<bold>Third-line&#x000a0;Treatment</bold>
</p>
        <p>Third-line treatments for PV include intravenous immunoglobulin (IVIG), cyclophosphamide, dapsone, immunoadsorption, and methotrexate.<xref ref-type="bibr" rid="article-26884.r66">[66]</xref><xref ref-type="bibr" rid="article-26884.r70">[70]</xref>&#x000a0;Some studies have suggested treatment with other agents, such as apremilast or cyclophosphamide; pain-controlling medications may also be necessary depending on the patient's involvement.<xref ref-type="bibr" rid="article-26884.r71">[71]</xref><xref ref-type="bibr" rid="article-26884.r72">[72]</xref><xref ref-type="bibr" rid="article-26884.r73">[73]</xref><xref ref-type="bibr" rid="article-26884.r72">[72]</xref></p>
        <p>
<bold>Emerging Therapies</bold>
</p>
        <p>Most of the emerging therapies that could be effective for PV are monoclonal antibodies, with the cost being a major restriction to large trials. Obinutuzumab, ofatumumab, and veltuzumab are anti-CD20 monoclonal antibodies that may be an alternative to rituximab. Other therapies that may offer hope in PV include medications&#x000a0;that target B-cell&#x02013;derived B-cell activating factor (BAFF), a proliferation-inducing ligand (APRIL), CD19, Bruton kinase (BTK), and interleukin (IL-4).<xref ref-type="bibr" rid="article-26884.r32">[32]</xref>&#x000a0;Future PV research should focus on better understanding the specific pathogenic molecules and cytokines, after which better therapies can be produced.<xref ref-type="bibr" rid="article-26884.r74">[74]</xref></p>
      </sec>
      <sec id="article-26884.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnoses for PV include:</p>
        <p>
<bold>IgA Pemphigus </bold>
</p>
        <p>IgA pemphigus is similar to&#x000a0;PV in that it has painful blisters, but IgA pemphigus does not present with oral mucosal blisters.&#x000a0;DIF and IIF can both help to differentiate PV from IgA pemphigus.<xref ref-type="bibr" rid="article-26884.r75">[75]</xref></p>
        <p>
<bold>Pemphigus Foliaceus</bold>
</p>
        <p>Pemphigus foliaceus is similar to PV in the fact that it is an autoimmune blistering disease; however, similarly to IgA pemphigus, pemphigus foliaceus does not affect the oral mucosa since it is mostly due to Dsg 1 autoantibodies. Pemphigus foliaceus is less common than PV.<xref ref-type="bibr" rid="article-26884.r76">[76]</xref></p>
        <p>
<bold>Paraneoplastic Pemphigus</bold>
</p>
        <p>Paraneoplastic pemphigus also presents with mucocutaneous vesicles and bullae similar to PV. Paraneoplastic pemphigus can be differentiated from PV using IIF&#x000a0;and immunoblot.<xref ref-type="bibr" rid="article-26884.r77">[77]</xref></p>
      </sec>
      <sec id="article-26884.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Follow-up and response to treatment of&#x000a0;PV should be monitored closely.&#x000a0;PV is an active disease and often requires dose adjustments and changes in medications&#x000a0;according to the response to treatment.&#x000a0;Septicemia is the leading cause of death in PV.<xref ref-type="bibr" rid="article-26884.r19">[19]</xref> A retrospective cohort study by Kridin et al. in Israel found that survival rates were lower in patients with PV compared with the general population. Patients who were diagnosed with PV at an older age had a lower survival rate. The median overall survival from the point of diagnosis was 10.1 years (0.2 to 29.8 years). There was not a statistically significant survival difference between men and women.<xref ref-type="bibr" rid="article-26884.r78">[78]</xref></p>
      </sec>
      <sec id="article-26884.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Systemic corticosteroids, which are the backbone of PV treatment, are well known for causing osteoporosis and other complications. Corticosteroids have been reported to cause fractures in 30% to 50% and cause osteonecrosis in 9% to 40% of patients receiving long-term therapy.<xref ref-type="bibr" rid="article-26884.r79">[79]</xref> The Fracture Risk Assessment (FRAX) is a tool used to further stratify the risk of osteoporotic fracture.<xref ref-type="bibr" rid="article-26884.r80">[80]</xref> Other common side effects from corticosteroids include hyperglycemia, insomnia, increased appetite, hypertension, edema, adrenal suppression, cataracts, and delayed wound healing.<xref ref-type="bibr" rid="article-26884.r81">[81]</xref></p>
        <p>A case-control study by Namazi et al. looked at the incidence of P-wave dispersion (PWD) in patients with PV. The authors reasoned that atrial fibrillation can be predicted by the presence of PWD and hypothesized that atrial fibrillation might be higher in PV patients. Patients were excluded if they had obesity, hyperlipidemia, hypertension, diabetes mellitus, and cardiopulmonary disease. The authors stated the limitations of their study included a small sample size of 90 patients and the use of corticosteroids was higher in the patients with PV. Regardless of those limitations, the incidence of PWD confirmed by electrocardiogram (ECG) was higher in the PV group than in the control group.<xref ref-type="bibr" rid="article-26884.r82">[82]</xref></p>
        <p>Other complications could include other autoimmune diseases and malignancy.<xref ref-type="bibr" rid="article-26884.r83">[83]</xref><xref ref-type="bibr" rid="article-26884.r84">[84]</xref><xref ref-type="bibr" rid="article-26884.r85">[85]</xref><xref ref-type="bibr" rid="article-26884.r86">[86]</xref><xref ref-type="bibr" rid="article-26884.r87">[87]</xref> Secondary infections may be common and should be prevented with a thorough care regimen, both with antifungal oral hygiene and careful avoidance of triggers that cause blistering.<xref ref-type="bibr" rid="article-26884.r88">[88]</xref>&#x000a0;Infections should be monitored carefully, as septicemia is the most common cause of death in patients with PV.<xref ref-type="bibr" rid="article-26884.r19">[19]</xref></p>
        <p>Patients with significant oral involvement may need dietary adjustments to prevent complications.<xref ref-type="bibr" rid="article-26884.r89">[89]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-26884.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient education should include close follow-up visits with their provider and specialists. Medication compliance is integral to the management of&#x000a0;PV and can be reinforced by the pharmacist's support. Patients&#x000a0;should be provided information on support groups and resources on&#x000a0;behavioral modulation, like dietary changes, to prevent the worsening of their disease.<xref ref-type="bibr" rid="article-26884.r90">[90]</xref><xref ref-type="bibr" rid="article-26884.r91">[91]</xref></p>
      </sec>
      <sec id="article-26884.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>PV&#x000a0;is a life-threatening autoimmune disease for which treatment is indicated. The goal of treatment in PV is to induce complete remission with minimal treatment-related adverse effects. Cutaneous and mucosal involvement in&#x000a0;PV can&#x000a0;cause significant pain and functional impairment. Local measures may help to improve patient symptoms. Due to the serious adverse effects, prolonged treatment with high doses of a systemic glucocorticoid is not recommended. A secondary&#x000a0;infection like herpes simplex infection should be considered when lesions fail to respond to treatment. An interprofessional approach, including social workers, wound care staff, dieticians, nurses, physician assistants, nurse practitioners, pharmacists, dentists, primary care physicians, hospitalists, and dermatologists, can optimize outcomes.</p>
      </sec>
      <sec id="article-26884.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26884&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26884">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/pemphigus-vulgaris/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26884">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26884/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26884">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-26884.s16">
        <fig id="article-26884.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Pemphigus Vulgaris <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pemphigus__vulgaris" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-26884.s17">
        <title>References</title>
        <ref id="article-26884.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patel</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wilken</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>FB</given-names>
              </name>
              <name>
                <surname>Sultani</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Bustos</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Duong</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zone</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Raychaudhuri</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Maverakis</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology of Autoimmune Bullous Diseases: Nature Versus Nurture.</article-title>
            <source>Indian J Dermatol</source>
            <year>2017</year>
            <season>May-Jun</season>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>262</fpage>
            <page-range>262-267</page-range>
            <pub-id pub-id-type="pmid">28584368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dickson</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Observations on Pemphigus.</article-title>
            <source>Lond Med J</source>
            <year>1788</year>
            <volume>9</volume>
            <issue>Pt 3</issue>
            <fpage>309</fpage>
            <page-range>309-324</page-range>
            <pub-id pub-id-type="pmid">29139718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jain</surname>
                <given-names>VR</given-names>
              </name>
              <name>
                <surname>Mahajan</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Rathi</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Biyani</surname>
                <given-names>VV</given-names>
              </name>
              <name>
                <surname>Ninama</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Marfatia</surname>
                <given-names>YS</given-names>
              </name>
            </person-group>
            <article-title>Oral Mucosal Lesions - A Study of 369 Cases.</article-title>
            <source>Indian Dermatol Online J</source>
            <year>2023</year>
            <season>Mar-Apr</season>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>213</fpage>
            <page-range>213-220</page-range>
            <pub-id pub-id-type="pmid">37089853</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The dysregulation of circulating innate lymphoid cells is related to autoantibodies in pemphigus vulgaris.</article-title>
            <source>Int Immunopharmacol</source>
            <year>2023</year>
            <month>Apr</month>
            <volume>117</volume>
            <fpage>109921</fpage>
            <pub-id pub-id-type="pmid">36841156</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drenovska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ivanova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vassileva</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shahid</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Naumova</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Association of specific HLA alleles and haplotypes with pemphigus vulgaris in the Bulgarian population.</article-title>
            <source>Front Immunol</source>
            <year>2022</year>
            <volume>13</volume>
            <fpage>901386</fpage>
            <pub-id pub-id-type="pmid">35983062</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salviano-Silva</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Farias</surname>
                <given-names>TDJ</given-names>
              </name>
              <name>
                <surname>Bumiller-Bini</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Castro</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Lobo-Alves</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Busch</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Pf&#x000f6;hler</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Worm</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goebeler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van Beek</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Franke</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wittig</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zillikens</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>de Almeida</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Hundt</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Boldt</surname>
                <given-names>ABW</given-names>
              </name>
              <name>
                <surname>Ibrahim</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Augusto</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Petzl-Erler</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Malheiros</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Genetic variability of immune-related lncRNAs: polymorphisms in LINC-PINT and LY86-AS1 are associated with pemphigus foliaceus susceptibility.</article-title>
            <source>Exp Dermatol</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>831</fpage>
            <page-range>831-840</page-range>
            <pub-id pub-id-type="pmid">33394553</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Seiffert-Sinha</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Patient genetics shape the autoimmune response in the blistering skin disease pemphigus vulgaris.</article-title>
            <source>Front Immunol</source>
            <year>2022</year>
            <volume>13</volume>
            <fpage>1064073</fpage>
            <pub-id pub-id-type="pmid">36703961</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Firooz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mazhar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of autoimmune diseases in the family members of patients with pemphigus vulgaris.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1994</year>
            <month>Sep</month>
            <volume>31</volume>
            <issue>3 Pt 1</issue>
            <fpage>434</fpage>
            <page-range>434-7</page-range>
            <pub-id pub-id-type="pmid">8077468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Szafer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Brautbar</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Tzfoni</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Frankel</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sherman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Hacham-Zadeh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aberer</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Tappeiner</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Holubar</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Detection of disease-specific restriction fragment length polymorphisms in pemphigus vulgaris linked to the DQw1 and DQw3 alleles of the HLA-D region.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1987</year>
            <month>Sep</month>
            <volume>84</volume>
            <issue>18</issue>
            <fpage>6542</fpage>
            <page-range>6542-5</page-range>
            <pub-id pub-id-type="pmid">2888115</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lombardi</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Mercuro</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Ruocco</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Lo Schiavo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lombari</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Guerrera</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Pirozzi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Manzo</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Common human leukocyte antigen alleles in pemphigus vulgaris and pemphigus foliaceus Italian patients.</article-title>
            <source>J Invest Dermatol</source>
            <year>1999</year>
            <month>Jul</month>
            <volume>113</volume>
            <issue>1</issue>
            <fpage>107</fpage>
            <page-range>107-10</page-range>
            <pub-id pub-id-type="pmid">10417627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tavakolpour</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus.</article-title>
            <source>Arch Dermatol Res</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>310</volume>
            <issue>2</issue>
            <fpage>95</fpage>
            <page-range>95-106</page-range>
            <pub-id pub-id-type="pmid">29110080</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crocker</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Radiation-induced pemphigus in a patient with an invasive ductal carcinoma of the breast: a case report.</article-title>
            <source>Oxf Med Case Reports</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>2020</volume>
            <issue>1</issue>
            <fpage>omaa001</fpage>
            <pub-id pub-id-type="pmid">32038873</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brenner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Drug-induced pemphigus.</article-title>
            <source>Clin Dermatol</source>
            <year>2011</year>
            <season>Jul-Aug</season>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>455</fpage>
            <page-range>455-7</page-range>
            <pub-id pub-id-type="pmid">21679874</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Feng</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jin</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Analysis of 6 cases of drug-induced pemphigus.</article-title>
            <source>Eur J Dermatol</source>
            <year>2011</year>
            <season>Sep-Oct</season>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>696</fpage>
            <page-range>696-9</page-range>
            <pub-id pub-id-type="pmid">21697060</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ruocco</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ruocco</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lo Schiavo</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brunetti</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Guerrera</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus: etiology, pathogenesis, and inducing or triggering factors: facts and controversies.</article-title>
            <source>Clin Dermatol</source>
            <year>2013</year>
            <season>Jul-Aug</season>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>374</fpage>
            <page-range>374-381</page-range>
            <pub-id pub-id-type="pmid">23806154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Celere</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Vernal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brochado</surname>
                <given-names>MJF</given-names>
              </name>
              <name>
                <surname>Segura-Mu&#x000f1;oz</surname>
                <given-names>SI</given-names>
              </name>
              <name>
                <surname>Roselino</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Geographical foci and epidemiological changes of pemphigus vulgaris in four decades in Southeastern Brazil.</article-title>
            <source>Int J Dermatol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>56</volume>
            <issue>12</issue>
            <fpage>1494</fpage>
            <page-range>1494-1496</page-range>
            <pub-id pub-id-type="pmid">28737218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Langan</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Smeeth</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hubbard</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Fleming</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>West</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study.</article-title>
            <source>BMJ</source>
            <year>2008</year>
            <month>Jul</month>
            <day>09</day>
            <volume>337</volume>
            <issue>7662</issue>
            <fpage>a180</fpage>
            <pub-id pub-id-type="pmid">18614511</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kneisel</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hertl</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune bullous skin diseases. Part 1: Clinical manifestations.</article-title>
            <source>J Dtsch Dermatol Ges</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>9</volume>
            <issue>10</issue>
            <fpage>844</fpage>
            <page-range>844-56; quiz 857</page-range>
            <pub-id pub-id-type="pmid">21955378</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Porro</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Seque</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Ferreira</surname>
                <given-names>MCC</given-names>
              </name>
              <name>
                <surname>Enokihara</surname>
                <given-names>MMSES</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus vulgaris.</article-title>
            <source>An Bras Dermatol</source>
            <year>2019</year>
            <month>Jul</month>
            <day>29</day>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>264</fpage>
            <page-range>264-278</page-range>
            <pub-id pub-id-type="pmid">31365654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kridin</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus group: overview, epidemiology, mortality, and comorbidities.</article-title>
            <source>Immunol Res</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>66</volume>
            <issue>2</issue>
            <fpage>255</fpage>
            <page-range>255-270</page-range>
            <pub-id pub-id-type="pmid">29479654</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vodo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sarig</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Sprecher</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>The Genetics of Pemphigus Vulgaris.</article-title>
            <source>Front Med (Lausanne)</source>
            <year>2018</year>
            <volume>5</volume>
            <fpage>226</fpage>
            <pub-id pub-id-type="pmid">30155467</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guptill</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Sleasman</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Steeland</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sips</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gelinas</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>de Haard</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Azar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Winthrop</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Effect of FcRn antagonism on protective antibodies and to vaccines in IgG-mediated autoimmune diseases pemphigus and generalised myasthenia gravis.</article-title>
            <source>Autoimmunity</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>55</volume>
            <issue>8</issue>
            <fpage>620</fpage>
            <page-range>620-631</page-range>
            <pub-id pub-id-type="pmid">36036539</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seo</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>WK</given-names>
              </name>
            </person-group>
            <article-title>A case of pemphigus vulgaris associated with ulcerative colitis.</article-title>
            <source>Intest Res</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>16</volume>
            <issue>1</issue>
            <fpage>147</fpage>
            <page-range>147-150</page-range>
            <pub-id pub-id-type="pmid">29422810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alshami</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Aswad</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Abdullah</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Desmogleins 1, 3, and E-cadherin immunohistochemical expression within mucocutaneous pemphigus vulgaris.</article-title>
            <source>Pan Afr Med J</source>
            <year>2022</year>
            <volume>42</volume>
            <fpage>186</fpage>
            <pub-id pub-id-type="pmid">36212929</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ishii</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Significance of anti-desmocollin autoantibodies in pemphigus.</article-title>
            <source>J Dermatol</source>
            <year>2023</year>
            <month>Feb</month>
            <volume>50</volume>
            <issue>2</issue>
            <fpage>132</fpage>
            <page-range>132-139</page-range>
            <pub-id pub-id-type="pmid">36578135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mihai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sitaru</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Immunopathology and molecular diagnosis of autoimmune bullous diseases.</article-title>
            <source>J Cell Mol Med</source>
            <year>2007</year>
            <season>May-Jun</season>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>462</fpage>
            <page-range>462-81</page-range>
            <pub-id pub-id-type="pmid">17521373</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hertl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eming</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Veldman</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>T cell control in autoimmune bullous skin disorders.</article-title>
            <source>J Clin Invest</source>
            <year>2006</year>
            <month>May</month>
            <volume>116</volume>
            <issue>5</issue>
            <fpage>1159</fpage>
            <page-range>1159-66</page-range>
            <pub-id pub-id-type="pmid">16670756</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sinha</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Sajda</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>The Evolving Story of Autoantibodies in Pemphigus Vulgaris: Development of the "Super Compensation Hypothesis".</article-title>
            <source>Front Med (Lausanne)</source>
            <year>2018</year>
            <volume>5</volume>
            <fpage>218</fpage>
            <pub-id pub-id-type="pmid">30155465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sitaru</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zillikens</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of blister induction by autoantibodies.</article-title>
            <source>Exp Dermatol</source>
            <year>2005</year>
            <month>Dec</month>
            <volume>14</volume>
            <issue>12</issue>
            <fpage>861</fpage>
            <page-range>861-75</page-range>
            <pub-id pub-id-type="pmid">16274453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hammers</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Stanley</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of Disease: Pemphigus and Bullous Pemphigoid.</article-title>
            <source>Annu Rev Pathol</source>
            <year>2016</year>
            <month>May</month>
            <day>23</day>
            <volume>11</volume>
            <fpage>175</fpage>
            <page-range>175-97</page-range>
            <pub-id pub-id-type="pmid">26907530</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amagai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tsunoda</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zillikens</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nagai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nishikawa</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1999</year>
            <month>Feb</month>
            <volume>40</volume>
            <issue>2 Pt 1</issue>
            <fpage>167</fpage>
            <page-range>167-70</page-range>
            <pub-id pub-id-type="pmid">10025740</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Didona</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Maglie</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Eming</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hertl</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus: Current and Future Therapeutic Strategies.</article-title>
            <source>Front Immunol</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>1418</fpage>
            <pub-id pub-id-type="pmid">31293582</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Amagai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Karpati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Prussick</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Klaus-Kovtun</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Stanley</surname>
                <given-names>JR</given-names>
              </name>
            </person-group>
            <article-title>Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic.</article-title>
            <source>J Clin Invest</source>
            <year>1992</year>
            <month>Sep</month>
            <volume>90</volume>
            <issue>3</issue>
            <fpage>919</fpage>
            <page-range>919-26</page-range>
            <pub-id pub-id-type="pmid">1522242</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hartmann</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Hariton</surname>
                <given-names>WV</given-names>
              </name>
              <name>
                <surname>Rahimi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hammers</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Ludwig</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Hundt</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>The human skin organ culture model as an optimal complementary tool for murine pemphigus models.</article-title>
            <source>Lab Anim</source>
            <year>2023</year>
            <month>Aug</month>
            <volume>57</volume>
            <issue>4</issue>
            <fpage>381</fpage>
            <page-range>381-395</page-range>
            <pub-id pub-id-type="pmid">36647613</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boch</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Dr&#x000e4;ger</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zillikens</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hudemann</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hammers</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Patzelt</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Langan</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Eming</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ludwig</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Bieber</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice.</article-title>
            <source>PLoS One</source>
            <year>2021</year>
            <volume>16</volume>
            <issue>11</issue>
            <fpage>e0259586</fpage>
            <pub-id pub-id-type="pmid">34731225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Egu</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Schmitt</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Waschke</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms Causing Acantholysis in Pemphigus-Lessons from Human Skin.</article-title>
            <source>Front Immunol</source>
            <year>2022</year>
            <volume>13</volume>
            <fpage>884067</fpage>
            <pub-id pub-id-type="pmid">35720332</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kawamura</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Muramatsu</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Orita</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mai</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sugai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Haga</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Fujimura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Miyauchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Izumi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Koga</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ishii</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ujiie</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Two cases of Hallopeau-type pemphigus vegetans with anti-desmoglein 1 and anti-desmocollin 3 antibodies without mucosal involvement.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2023</year>
            <month>Apr</month>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>e508</fpage>
            <page-range>e508-e510</page-range>
            <pub-id pub-id-type="pmid">36305887</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jindal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pai</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Utility of oral mucosa as a substrate for the serodiagnosis of pemphigus: A descriptive analysis.</article-title>
            <source>Indian J Dermatol Venereol Leprol</source>
            <year>2022</year>
            <season>Mar-Apr</season>
            <volume>88</volume>
            <issue>2</issue>
            <fpage>156</fpage>
            <page-range>156-161</page-range>
            <pub-id pub-id-type="pmid">34491669</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ishii</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yoshida</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Stanley</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Yamagami</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Amagai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ishiko</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus Vulgaris and Foliaceus IgG Autoantibodies Directly Block Heterophilic Transinteraction between Desmoglein and Desmocollin.</article-title>
            <source>J Invest Dermatol</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>140</volume>
            <issue>10</issue>
            <fpage>1919</fpage>
            <page-range>1919-1926.e7</page-range>
            <pub-id pub-id-type="pmid">32142800</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmitt</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Waschke</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Autoantibody-Specific Signalling in Pemphigus.</article-title>
            <source>Front Med (Lausanne)</source>
            <year>2021</year>
            <volume>8</volume>
            <fpage>701809</fpage>
            <pub-id pub-id-type="pmid">34434944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oktarina</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>van der Wier</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Diercks</surname>
                <given-names>GF</given-names>
              </name>
              <name>
                <surname>Jonkman</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Pas</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis.</article-title>
            <source>Br J Dermatol</source>
            <year>2011</year>
            <month>Sep</month>
            <volume>165</volume>
            <issue>3</issue>
            <fpage>552</fpage>
            <page-range>552-62</page-range>
            <pub-id pub-id-type="pmid">21692763</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sielski</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Baker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>DePasquale</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Attwood</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Seiffert-Sinha</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>Desmoglein compensation hypothesis fidelity assessment in Pemphigus.</article-title>
            <source>Front Immunol</source>
            <year>2022</year>
            <volume>13</volume>
            <fpage>969278</fpage>
            <pub-id pub-id-type="pmid">36211362</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garg</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bhojani</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Non infective bullous lesions: a diagnostic challenge in a minimally equipped centre- based solely on microscopic findings.</article-title>
            <source>Afr Health Sci</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>20</volume>
            <issue>2</issue>
            <fpage>885</fpage>
            <page-range>885-890</page-range>
            <pub-id pub-id-type="pmid">33163055</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Papara</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Danescu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rogojan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Leucuta</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Candrea</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zillikens</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Baican</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Lymphocyte-predominant lesional inflammatory infiltrates of the skin are associated with mucosal-dominant phenotype in pemphigus.</article-title>
            <source>J Cutan Pathol</source>
            <year>2023</year>
            <month>Aug</month>
            <volume>50</volume>
            <issue>8</issue>
            <fpage>754</fpage>
            <page-range>754-762</page-range>
            <pub-id pub-id-type="pmid">36680509</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gottesman</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Abedi</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Gottlieb</surname>
                <given-names>GJ</given-names>
              </name>
            </person-group>
            <article-title>Hailey-Hailey-Like Pattern of Acantholysis on the Scalp Should Raise the Possibility of Incipient Pemphigus Vulgaris.</article-title>
            <source>Am J Dermatopathol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>41</volume>
            <issue>4</issue>
            <fpage>286</fpage>
            <page-range>286-288</page-range>
            <pub-id pub-id-type="pmid">30640761</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>See</surname>
                <given-names>SHC</given-names>
              </name>
              <name>
                <surname>Peternel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>North</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Distinguishing histopathologic features of acantholytic dermatoses and the pattern of acantholytic hypergranulosis.</article-title>
            <source>J Cutan Pathol</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>46</volume>
            <issue>1</issue>
            <fpage>6</fpage>
            <page-range>6-15</page-range>
            <pub-id pub-id-type="pmid">30203619</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ng</surname>
                <given-names>JKM</given-names>
              </name>
              <name>
                <surname>Cheung</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>PCL</given-names>
              </name>
              <name>
                <surname>Ip</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>JJX</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>AWS</given-names>
              </name>
            </person-group>
            <article-title>A rare presentation of pemphigus vegetans as an isolated vegetative lesion-Review of histopathological clues and treatment effects in multiple biopsy specimens.</article-title>
            <source>J Cutan Pathol</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>50</volume>
            <issue>3</issue>
            <fpage>201</fpage>
            <page-range>201-208</page-range>
            <pub-id pub-id-type="pmid">36502456</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jabri</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hali</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Elkaroini</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Mahdaoui</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Alatawna</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chiheb</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus vegetans-Neumann variant of the vulva.</article-title>
            <source>Int J Dermatol</source>
            <year>2023</year>
            <month>Jun</month>
            <volume>62</volume>
            <issue>6</issue>
            <fpage>841</fpage>
            <page-range>841-842</page-range>
            <pub-id pub-id-type="pmid">37098705</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davarmanesh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zahed</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sookhakian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jehbez</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Oral Pemphigus Vulgaris Treatment with Corticosteroids and Azathioprine: A Long-Term Study in Shiraz, Iran.</article-title>
            <source>Evid Based Complement Alternat Med</source>
            <year>2022</year>
            <volume>2022</volume>
            <fpage>7583691</fpage>
            <pub-id pub-id-type="pmid">36164397</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Korbl</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Brusch</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lucas</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>von Nida</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wood</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Leecy</surname>
                <given-names>TN</given-names>
              </name>
              <name>
                <surname>Harvey</surname>
                <given-names>NT</given-names>
              </name>
            </person-group>
            <article-title>A case of severe cutaneous and mucosal erosions.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>45</volume>
            <issue>6</issue>
            <fpage>780</fpage>
            <page-range>780-782</page-range>
            <pub-id pub-id-type="pmid">32410330</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Long</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lu</surname>
                <given-names>Q</given-names>
              </name>
            </person-group>
            <article-title>Vitamin D status in patients with autoimmune bullous dermatoses: a meta-analysis.</article-title>
            <source>J Dermatolog Treat</source>
            <year>2022</year>
            <month>May</month>
            <volume>33</volume>
            <issue>3</issue>
            <fpage>1356</fpage>
            <page-range>1356-1367</page-range>
            <pub-id pub-id-type="pmid">32799714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lamichhane</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chaudhary</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Delayed Diagnosis of Pemphigus Vulgaris Initially Presenting as an Oral Ulcer: A Case Report.</article-title>
            <source>JNMA J Nepal Med Assoc</source>
            <year>2022</year>
            <month>Jul</month>
            <day>01</day>
            <volume>60</volume>
            <issue>251</issue>
            <fpage>641</fpage>
            <page-range>641-643</page-range>
            <pub-id pub-id-type="pmid">36705190</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Silva</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Nasser</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Payne</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Stoopler</surname>
                <given-names>ET</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus Vulgaris.</article-title>
            <source>J Emerg Med</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>56</volume>
            <issue>1</issue>
            <fpage>102</fpage>
            <page-range>102-104</page-range>
            <pub-id pub-id-type="pmid">30503724</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kavala</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Topalo&#x0011f;lu Demir</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zindanci</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Can</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Turko&#x0011f;lu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zemheri</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cam</surname>
                <given-names>OH</given-names>
              </name>
              <name>
                <surname>Teksen</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Genital involvement in pemphigus vulgaris (PV): correlation with clinical and cervicovaginal Pap smear findings.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2015</year>
            <month>Oct</month>
            <volume>73</volume>
            <issue>4</issue>
            <fpage>655</fpage>
            <page-range>655-9</page-range>
            <pub-id pub-id-type="pmid">26194705</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Munhoz de Paula Alves Coelho</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Stall</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Henrique Condeixa de Fran&#x000e7;a</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cristina de Carvalho Tavares</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Stefanello Bublitz</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Loos</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Carvalho Costa</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fronza J&#x000fa;nior</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus vulgaris of the cervix: diagnostic difficulties associated with the Pap test.</article-title>
            <source>Diagn Cytopathol</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>43</volume>
            <issue>8</issue>
            <fpage>635</fpage>
            <page-range>635-7</page-range>
            <pub-id pub-id-type="pmid">25728997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akhyani</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chams-Davatchi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Naraghi</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Daneshpazhooh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Toosi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Asgari</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Malekhami</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Cervicovaginal involvement in pemphigus vulgaris: a clinical study of 77 cases.</article-title>
            <source>Br J Dermatol</source>
            <year>2008</year>
            <month>Mar</month>
            <volume>158</volume>
            <issue>3</issue>
            <fpage>478</fpage>
            <page-range>478-82</page-range>
            <pub-id pub-id-type="pmid">18070212</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hertl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Veldman</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus--paradigm of autoantibody-mediated autoimmunity.</article-title>
            <source>Skin Pharmacol Appl Skin Physiol</source>
            <year>2001</year>
            <season>Nov-Dec</season>
            <volume>14</volume>
            <issue>6</issue>
            <fpage>408</fpage>
            <page-range>408-18</page-range>
            <pub-id pub-id-type="pmid">11598441</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xie</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bilgic</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abu Alrub</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dicle</surname>
                <given-names>&#x000d6;</given-names>
              </name>
              <name>
                <surname>Murrell</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>Clinical manifestations of alopecia in autoimmune blistering diseases: A cross-sectional study.</article-title>
            <source>JAAD Int</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>10</volume>
            <fpage>6</fpage>
            <page-range>6-13</page-range>
            <pub-id pub-id-type="pmid">36387063</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmidt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kasperkiewicz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Joly</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus.</article-title>
            <source>Lancet</source>
            <year>2019</year>
            <month>Sep</month>
            <day>07</day>
            <volume>394</volume>
            <issue>10201</issue>
            <fpage>882</fpage>
            <page-range>882-894</page-range>
            <pub-id pub-id-type="pmid">31498102</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Helm</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Helm</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Clebak</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Foulke</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Autoimmune Skin Conditions: Autoimmune Blistering Disease.</article-title>
            <source>FP Essent</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>526</volume>
            <fpage>13</fpage>
            <page-range>13-17</page-range>
            <pub-id pub-id-type="pmid">36913658</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asokan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rai</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Boppe</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Umamaheswari</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of the Role of Oral Mucosal Direct Immunofluorescence and Salivary Desmoglein 1 and 3 Enzyme-Linked Immunosorbent Assay in Patients With Oral Mucosal Pemphigus.</article-title>
            <source>Indian Dermatol Online J</source>
            <year>2022</year>
            <season>Sep-Oct</season>
            <volume>13</volume>
            <issue>5</issue>
            <fpage>617</fpage>
            <page-range>617-619</page-range>
            <pub-id pub-id-type="pmid">36304655</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pohla-Gubo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hintner</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Direct and indirect immunofluorescence for the diagnosis of bullous autoimmune diseases.</article-title>
            <source>Dermatol Clin</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>365</fpage>
            <page-range>365-72, vii</page-range>
            <pub-id pub-id-type="pmid">21605801</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hocke</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Krauth</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Krause</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gerlach</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Warnem&#x000fc;nde</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Affeldt</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>van Beek</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Voigt</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Computer-aided classification of indirect immunofluorescence patterns on esophagus and split skin for the detection of autoimmune dermatoses.</article-title>
            <source>Front Immunol</source>
            <year>2023</year>
            <volume>14</volume>
            <fpage>1111172</fpage>
            <pub-id pub-id-type="pmid">36926325</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harman</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Exton</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Groves</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Hampton</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Mohd Mustapa</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Setterfield</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Yesudian</surname>
                <given-names>PD</given-names>
              </name>
            </person-group>
            <article-title>British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017.</article-title>
            <source>Br J Dermatol</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>177</volume>
            <issue>5</issue>
            <fpage>1170</fpage>
            <page-range>1170-1201</page-range>
            <pub-id pub-id-type="pmid">29192996</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hertl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jedlickova</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Karpati</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Marinovic</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Uzun</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yayli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mimouni</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Borradori</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Feliciani</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ioannides</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Joly</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kowalewski</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Zambruno</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zillikens</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jonkman</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus. S2 Guideline for diagnosis and treatment--guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV).</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2015</year>
            <month>Mar</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>405</fpage>
            <page-range>405-14</page-range>
            <pub-id pub-id-type="pmid">25338479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kridin</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Emerging treatment options for the management of pemphigus vulgaris.</article-title>
            <source>Ther Clin Risk Manag</source>
            <year>2018</year>
            <volume>14</volume>
            <fpage>757</fpage>
            <page-range>757-778</page-range>
            <pub-id pub-id-type="pmid">29740210</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r67">
          <label>67</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Benjamin</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Goyal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lappin</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <chapter-title>Disease-Modifying Antirheumatic Drugs (DMARD)</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>3</day>
            <pub-id pub-id-type="pmid">29939640</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r68">
          <label>68</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Mohammadi</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Kassim</surname>
                <given-names>TA</given-names>
              </name>
            </person-group>
            <chapter-title>Azathioprine</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>1</day>
            <pub-id pub-id-type="pmid">31194347</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Davis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dickson</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Daniel</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Nepal</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zanussi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Miller-Fleming</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Straub</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>WQ</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cox</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Hung</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Feng</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>CP</given-names>
              </name>
            </person-group>
            <article-title>Association Between Genetically Predicted Expression of TPMT and Azathioprine Adverse Events.</article-title>
            <source>Res Sq</source>
            <year>2023</year>
            <month>Jan</month>
            <day>13</day>
            <pub-id pub-id-type="pmid">36711487</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murrell</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Pe&#x000f1;a</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Joly</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Marinovic</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Diaz</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Sinha</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Payne</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Daneshpazhooh</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eming</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jonkman</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Mimouni</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Borradori</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Yamagami</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lehman</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Saleh</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Culton</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Czernik</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zone</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Fivenson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ujiie</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wozniak</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Akman-Karaka&#x0015f;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bernard</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Korman</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Caux</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Drenovska</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Prost-Squarcioni</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vassileva</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Feldman</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Cardones</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Bauer</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ioannides</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jedlickova</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Palisson</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Patsatsi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Uzun</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yayli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zillikens</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Amagai</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hertl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Aoki</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Grando</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Shimizu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Baum</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cianchini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Feliciani</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Iranzo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mascar&#x000f3;</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Kowalewski</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Groves</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Harman</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Marinkovich</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Maverakis</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Werth</surname>
                <given-names>VP</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and management of pemphigus: Recommendations of an international panel of experts.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>82</volume>
            <issue>3</issue>
            <fpage>575</fpage>
            <page-range>575-585.e1</page-range>
            <pub-id pub-id-type="pmid">29438767</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garcia</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>OU</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Novel pain management therapies for patients with pemphigus.</article-title>
            <source>Int J Dermatol</source>
            <year>2023</year>
            <month>Apr</month>
            <volume>62</volume>
            <issue>4</issue>
            <fpage>575</fpage>
            <page-range>575-578</page-range>
            <pub-id pub-id-type="pmid">35781697</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sigmund</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Winkler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Engelmayer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kugelmann</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Egu</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Steinert</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Fuchs</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hiermaier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Radeva</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Bayerbach</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Butz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Kotschi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hudemann</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hertl</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yeruva</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Yazdi</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Ghoreschi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Vielmuth</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Waschke</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Apremilast prevents blistering in human epidermis and stabilizes keratinocyte adhesion in pemphigus.</article-title>
            <source>Nat Commun</source>
            <year>2023</year>
            <month>Jan</month>
            <day>09</day>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>116</fpage>
            <pub-id pub-id-type="pmid">36624106</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patil</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mustaq</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hosmani</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>ZA</given-names>
              </name>
              <name>
                <surname>Yadalam</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>ZH</given-names>
              </name>
              <name>
                <surname>Bhandi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Awan</surname>
                <given-names>KH</given-names>
              </name>
            </person-group>
            <article-title>Advancement in therapeutic strategies for immune-mediated oral diseases.</article-title>
            <source>Dis Mon</source>
            <year>2023</year>
            <month>Jan</month>
            <volume>69</volume>
            <issue>1</issue>
            <fpage>101352</fpage>
            <pub-id pub-id-type="pmid">35339251</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r74">
          <label>74</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bilgic</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Murrell</surname>
                <given-names>DF</given-names>
              </name>
            </person-group>
            <article-title>What is novel in the clinical management of pemphigus.</article-title>
            <source>Expert Rev Clin Pharmacol</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>12</volume>
            <issue>10</issue>
            <fpage>973</fpage>
            <page-range>973-980</page-range>
            <pub-id pub-id-type="pmid">31550941</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r75">
          <label>75</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Aslanova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yarrarapu</surname>
                <given-names>SNS</given-names>
              </name>
              <name>
                <surname>Syed</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Zito</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <chapter-title>IgA Pemphigus</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>5</month>
            <day>1</day>
            <pub-id pub-id-type="pmid">30085605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r76">
          <label>76</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Lepe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Yarrarapu</surname>
                <given-names>SNS</given-names>
              </name>
              <name>
                <surname>Zito</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <chapter-title>Pemphigus Foliaceus</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">29763004</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r77">
          <label>77</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Kappius</surname>
                <given-names>RH</given-names>
              </name>
              <name>
                <surname>Ufkes</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Thiers</surname>
                <given-names>BH</given-names>
              </name>
            </person-group>
            <chapter-title>Paraneoplastic Pemphigus</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>5</month>
            <day>8</day>
            <pub-id pub-id-type="pmid">31536300</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r78">
          <label>78</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kridin</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zelber-Sagi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bergman</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Pemphigus Vulgaris and Pemphigus Foliaceus: Differences in Epidemiology and Mortality.</article-title>
            <source>Acta Derm Venereol</source>
            <year>2017</year>
            <month>Oct</month>
            <day>02</day>
            <volume>97</volume>
            <issue>9</issue>
            <fpage>1095</fpage>
            <page-range>1095-1099</page-range>
            <pub-id pub-id-type="pmid">28536732</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r79">
          <label>79</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weinstein</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Glucocorticoid-induced osteoporosis and osteonecrosis.</article-title>
            <source>Endocrinol Metab Clin North Am</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>41</volume>
            <issue>3</issue>
            <fpage>595</fpage>
            <page-range>595-611</page-range>
            <pub-id pub-id-type="pmid">22877431</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r80">
          <label>80</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lane</surname>
                <given-names>NE</given-names>
              </name>
            </person-group>
            <article-title>Glucocorticoid-Induced Osteoporosis: New Insights into the Pathophysiology and Treatments.</article-title>
            <source>Curr Osteoporos Rep</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-7</page-range>
            <pub-id pub-id-type="pmid">30685820</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r81">
          <label>81</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Puckett</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gabbar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bokhari</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <chapter-title>Prednisone</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>19</day>
            <pub-id pub-id-type="pmid">30521230</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r82">
          <label>82</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Namazi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ariaeenejad</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Azad</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Pishgahi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Risk of Atrial Fibrillation in Pemphigus Vulgaris.</article-title>
            <source>Indian Dermatol Online J</source>
            <year>2018</year>
            <season>Jul-Aug</season>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>275</fpage>
            <page-range>275-277</page-range>
            <pub-id pub-id-type="pmid">30050823</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r83">
          <label>83</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paracha</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Sagheer</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>AQ</given-names>
              </name>
            </person-group>
            <article-title>A clinic-epidemiological study of 148 patients of pemphigus at Lady Reading Hospital, Peshawar: a case series.</article-title>
            <source>J Pak Med Assoc</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>73</volume>
            <issue>3</issue>
            <fpage>659</fpage>
            <page-range>659-662</page-range>
            <pub-id pub-id-type="pmid">36932776</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r84">
          <label>84</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maruyama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Yamazaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ab&#x000e9;</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kato</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kano</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sumita</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Tomihara</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tanuma</surname>
                <given-names>JI</given-names>
              </name>
            </person-group>
            <article-title>Liquid-based cytology for differentiating two cases of pemphigus vulgaris from oral squamous cell carcinoma.</article-title>
            <source>Diagn Cytopathol</source>
            <year>2023</year>
            <month>May</month>
            <volume>51</volume>
            <issue>5</issue>
            <fpage>E170</fpage>
            <page-range>E170-E175</page-range>
            <pub-id pub-id-type="pmid">36762831</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r85">
          <label>85</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miyachi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Konishi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Matsui</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fushimi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Inozume</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Yasunaga</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Clinical course and outcomes of pemphigus vulgaris and foliaceus: A retrospective study using a nationwide database in Japan.</article-title>
            <source>J Dermatol</source>
            <year>2023</year>
            <month>Feb</month>
            <volume>50</volume>
            <issue>2</issue>
            <fpage>212</fpage>
            <page-range>212-221</page-range>
            <pub-id pub-id-type="pmid">36424909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r86">
          <label>86</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pankakoski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kluger</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sintonen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Panelius</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Clinical manifestations and comorbidities of pemphigus: a retrospective case-control study in southern Finland.</article-title>
            <source>Eur J Dermatol</source>
            <year>2022</year>
            <month>Jul</month>
            <day>01</day>
            <volume>32</volume>
            <issue>4</issue>
            <fpage>480</fpage>
            <page-range>480-486</page-range>
            <pub-id pub-id-type="pmid">36301748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r87">
          <label>87</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karakioulaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Murrell</surname>
                <given-names>DF</given-names>
              </name>
              <name>
                <surname>Kyriakou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Patsatsi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Investigation of comorbid autoimmune diseases in women with autoimmune bullous diseases: An interplay of autoimmunity and practical implications.</article-title>
            <source>Int J Womens Dermatol</source>
            <year>2022</year>
            <month>Oct</month>
            <volume>8</volume>
            <issue>3</issue>
            <fpage>e053</fpage>
            <pub-id pub-id-type="pmid">36225612</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r88">
          <label>88</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kadota</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Miyashita</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Fukushima</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oryoji</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hanada</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yoshida</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fujita</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tachibana</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Successful Management of a Severe Sacral Pressure Injury Penetrating to the Retroperitoneum.</article-title>
            <source>Wounds</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>33</volume>
            <issue>3</issue>
            <fpage>E24</fpage>
            <page-range>E24-E27</page-range>
            <pub-id pub-id-type="pmid">33914698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r89">
          <label>89</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Solanki</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Nair</surname>
                <given-names>PMK</given-names>
              </name>
            </person-group>
            <article-title>Lifestyle medicine approach in managing pemphigus vulgaris: A case report.</article-title>
            <source>Explore (NY)</source>
            <year>2023</year>
            <season>Jul-Aug</season>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>617</fpage>
            <page-range>617-620</page-range>
            <pub-id pub-id-type="pmid">36646613</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r90">
          <label>90</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Czerninski</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Zadik</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kartin-Gabbay</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Touger-Decker</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Dietary alterations in patients with oral vesiculoulcerative diseases.</article-title>
            <source>Oral Surg Oral Med Oral Pathol Oral Radiol</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>117</volume>
            <issue>3</issue>
            <fpage>319</fpage>
            <page-range>319-23</page-range>
            <pub-id pub-id-type="pmid">24144994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26884.r91">
          <label>91</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>H&#x000fc;bner</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sarhan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Schauer</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Use of Complementary and Alternative Medicine in Patients with Autoimmune Bullous Dermatoses: A Cohort Study Analysis of a Rare Disease Group.</article-title>
            <source>Complement Med Res</source>
            <year>2023</year>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>221</fpage>
            <page-range>221-229</page-range>
            <pub-id pub-id-type="pmid">36646063</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
